Skip to content

Our Company
Pipeline
Science
Investors
Careers
Contact

Positive Efficacy and Favorable Safety of Barzolvolimab in Chronic Inducible Urticaria: Phase 2 Trial Results

October 1, 2024

info@celldex.com

Locations

53 Frontage Road Ste 220
Hampton NJ 08827
(908) 454-7120

300 George Street Ste 530
New Haven, CT 06511
(203) 483-3500

151 Martine Street
Fall River, MA 02723
(508) 742-4300

160 Gould Street Ste 202
Needham, MA 02494
(781) 433-0771

© 2025 Celldex Therapeutics. All Rights Reserved.

Privacy Policy. Research Conflicts of Interest Policy. Terms of Use. Site Map.

Top